Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Natural Health Trends (NHTC) Construction in Progress (2016 - 2023)

Natural Health Trends (NHTC) has disclosed Construction in Progress for 10 consecutive years, with $40000.0 as the latest value for Q4 2023.

  • For Q4 2023, Construction in Progress rose 33.33% year-over-year to $40000.0; the TTM value through Dec 2023 reached $40000.0, up 33.33%, while the annual FY2023 figure was $40000.0, 33.33% up from the prior year.
  • Construction in Progress hit $40000.0 in Q4 2023 for Natural Health Trends, up from $30000.0 in the prior quarter.
  • Across five years, Construction in Progress topped out at $173000.0 in Q4 2021 and bottomed at $30000.0 in Q4 2022.
  • Average Construction in Progress over 4 years is $71000.0, with a median of $40500.0 recorded in 2020.
  • Year-over-year, Construction in Progress soared 321.95% in 2021 and then crashed 82.66% in 2022.
  • Natural Health Trends' Construction in Progress stood at $41000.0 in 2020, then skyrocketed by 321.95% to $173000.0 in 2021, then plummeted by 82.66% to $30000.0 in 2022, then soared by 33.33% to $40000.0 in 2023.
  • According to Business Quant data, Construction in Progress over the past three periods came in at $40000.0, $30000.0, and $173000.0 for Q4 2023, Q4 2022, and Q4 2021 respectively.